Submit your image related to Pathways to be featured!

Get Social

Submit your Twitter account related to Multicellular Organismal Development to be featured!

Blogs

Submit your blog on Multicellular Organismal Development to be featured!

Events

Submit your event on Multicellular Organismal Development to be featured!

Videos

Submit your video on Multicellular Organismal Development to be featured!

Charities

Submit your charity on Multicellular Organismal Development to be featured!

Multicellular Organismal Development Pathway Bioinformatics

Disease and disorder research has been conducted in relation to the Multicellular Organismal Development Pathway and Tumor Angiogenesis, Lupus Erythematosus, Systemic, Tissue Adhesions, Sarcoma, Reticuloendothelial Hyperplasia. The study of the Multicellular Organismal Development Pathway has been mentioned in research publications which can be found using our bioinformatics tool below. The Multicellular Organismal Development Pathway has been researched in relation to Angiogenesis, Protein Phosphorylation, Transport, Cell Adhesion, Cell-cell Signaling. The Multicellular Organismal Development Pathway complements our catalog of research reagents including antibodies and ELISA kits against ROUS SARCOMA ONCOGENE, MAPK, MASCOT, EP300, GLI3.

Top Research Reagents

We have 1615 products for the study of the Multicellular Organismal Development Pathway that can be applied to Chromatin Immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.

NBP1-90351
Western Blot: PKC delta Antibody [NBP1-90351] - Analysis in control (vector only transfected HEK293T lysate) and PRKCD over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).Immunocytochemistry/Immunofluorescence: PKC delta Antibody [NBP1-90351] - Immunofluorescent staining of human cell line U-2 OS shows localization to cytosol.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC

NBP2-29661
ELISA: Human, Mouse, Rat RelA/NFkB p65 ELISA Kit (Colorimetric) [NBP2-29661] - Standard curve using the internal RelA standard.ELISA: Human, Mouse, Rat RelA/NFkB p65 ELISA Kit (Colorimetric) [NBP2-29661] - Nuclear translocation of NF-kB p65 with LPS in Jurkat cells. Jurkat cells, grown to a density of 2X10(6) cells/ml, were treated with LPS (15 ug/ml). The cells were harvested at various indicated time points, and cell lysates were tested in Western analysis using NB100-56712 and also in this ELISA Kit.


Species Human, Mouse, Rat
Applications ELISA

95 Publications
AF2685
Western blot shows lysates of MDA-MB-468 human breast cancer cell line and HepG2 human hepatocellular carcinoma cell line untreated (-) or treated (+) with 50 µM pervanadate (PV) for 10 minutes. PVDF membrane was probed with 1 µg/mL of Rabbit Anti-Human Phospho-Src (Y419) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2685), followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # <a class=Src phosphorylated at Y419 was detected in immersion fixed paraffin-embedded sections of human colon using Rabbit Anti-Human Phospho-Src (Y419) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2685) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Rabbit HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # <a class=

Rabbit Polyclonal
Species Human
Applications WB, Simple Western, IHC

     1 Review

10 Publications
AF3690
Western blot shows lysates of mouse embryo tissue. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human/Mouse GLI-3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3690) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # <a class=Jurkat human acute T cell leukemia cell line treated with 50 ng/mL PMA and 200 ng/mL calcium ionomycin for 30 minutes was fixed using formaldehyde, resuspended in lysis buffer, and sonicated to shear chromatin. GLI‑3/DNA complexes were immunoprecipitated using 5 μg Goat Anti-Human/Mouse GLI‑3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3690) or control antibody (Catalog # <A class=NoLineLink href=

Goat Polyclonal
Species Human, Mouse
Applications WB, ChIP, ICC

     3 Reviews

102 Publications
DVE00
N/A VEGF [HRP]N/A VEGF [HRP]


Species Human
Applications ELISA

686 Publications
DRT100
N/A TNF RI/TNFRSF1A [HRP]N/A TNF RI/TNFRSF1A [HRP]


Species Human
Applications ELISA

86 Publications
NBP2-45912
Western Blot: SCYL1BP1 Antibody (4F11) [NBP2-45912] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SCYL1BP1.Immunohistochemistry: SCYL1BP1 Antibody (4F11) [NBP2-45912] - Analysis of Carcinoma of Human thyroid tissue.

Mouse Monoclonal
Species Human
Applications WB, IHC, IHC-P

NBP2-76347
Immunohistochemistry-Paraffin: OXTR Antibody [NBP2-76347] - Negative Control showing staining of paraffin embedded Human Ovary, with no primary antibody.Flow Cytometry: OXTR Antibody [NBP2-76347] - Analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (1 ug/mL). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.

Goat Polyclonal
Species Human
Applications Flow, IHC, IHC-P

NB110-68136
Flow (Intracellular): Tenascin C Antibody (4C8MS) [NB110-68136] - Figure A: Intracellular stain performed on U87MG Cells with Tenascin C (4C8MS) antibody NB110-68136 (blue) and a matched isotype control NBP1-97005 (orange). Cells were fixed with 4% paraformaldehyde, following fixation, cells were permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1 ug/mL for 30 minutes at room temperature, followed by mouse F(ab)2 IgG (H+L) APC-conjugated secondary antibody [F0101B, R&D Systems].Figure B: U87MG Cells were either untreated (orange) or treated with 3uM Monensin (blue). An intracellular stain was performed with Tenascin C (4C8MS) antibody NB110-68136. Cells were fixed with 4% paraformaldehyde, following fixation, cells were permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1 ug/mL for 30 minutes at room temperature, followed by mouse F(ab)2 IgG (H+L) APC-conjugated secondary antibody [F0101B, R&D Systems].Western Blot: Tenascin C Antibody (4C8MS) [NB110-68136] - Regulation of Tenascin C expression and its effect on fibrotic responses. Confluent foreskin fibroblasts were incubated with TGF-beta (10 ng ml-1 or indicated concentrations) or Tenascin C (TNC) for 24 or 72 h or indicated periods. Whole-cell lysates, culture media and RNA were examined by western analysis (upper panels) and qPCR (lower panel). Representative immunoblots or qPCR results (means+/-s.e.m. of triplicate determinations). S, secreted; L, lysates. Image collected and cropped by CiteAb from the following publication (https://www.nature.com/doifinder/10.1038/ncomms11703), licensed under a CC-BY license.

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, ELISA, Flow

     2 Reviews

26 Publications
NB100-616
Immunocytochemistry/Immunofluorescence: KAT3B/p300 Antibody (RW105) [NB100-616] - HeLa cells were fixed in 4% paraformaldehyde for 10 min and permeabilized in 0.05% Triton X-100 in PBS for 5 minutes. The cells were incubated with anti-KAT3B  Antibody (RW105)) at 5ug/ml for 60 minutes at room temperature and detected with an anti-mouse Dylight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue).  Cells were imaged using a 100X objective.Western Blot: KAT3B/p300 Antibody (RW105) [NB100-616] - p300 detected in a HeLa nuclear extract using NB 100-616 (1:250).  ECL: 20 minute exposure.

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, EM, Flow

14 Publications

Related Genes

The Multicellular Organismal Development Pathway has been researched against:

Related Diseases

The Multicellular Organismal Development Pathway has been studied in relation to diseases such as:

Related PTMs

The Multicellular Organismal Development Pathway has been studied in relation to posttranslational modifications (PTMs) including: